AC Immune SA - Company Profile
Powered by 
All the data and insights you need on AC Immune SA in one report.
$295
- Save hours of research time and resources with
our up-to-date AC Immune SA Strategy Report
- Understand AC Immune SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
AC Immune SA (AC Immune) is a clinical stage biopharmaceutical company that discovers, designs and develops novel small molecules, vaccines and antibodies for the prevention, diagnosis and treatment of neurodegenerative diseases based on its two proprietary technology platforms: SupraAntigen and Morphomer. The company operates through one reportable segment which includes discovering and developing therapeutic and diagnostic products targeting misfolded proteins.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer